Replies to post #2599 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

IDIX Insider Shareholdings

[Updated for option awards to executive officers on 2/13/09*.
Options listed below include both vested and non-vested holdings.]

 
 Executive Officers  
 JP Sommadossi, CEO       2,220K shares  1,806 options 
 Ron Renaud, CFO             15K shares   455K options 
 Doug Mayers, CMO            30K shares   260K options 
 David Standring, EVP Bio      0 shares   115K options 
 John Weidenbruch, Gen Cnsl  15K shares   275K options 
 Paul Fanning, SVP HR         1K shares    70K options 
 -- 
 Six executive officers   2,281K shares 2,981K options

 
 Independent directors  
 Charles Cramb                7K shares   120K options 
 Wayne Hockmeyer             42K shares    80K options 
 Thomas Hodgson              42K shares    80K options 
 Denise Pollard-Knight         0 shares    60K options 
 Pamela Thomas-Graham          0 shares    95K options 
 -- 
 Five independent dirctrs    91K shares   435K options

 
 All officers/directors   2,372K shares 3,416K options

*Feb 2009 option awards, along with 2009 executive salaries and bonus targets, are detailed in:
http://sec.gov/Archives/edgar/data/1093649/000095013509001040/b74290ipe8vk.htm